|
|||||||
" Ramelteon, C16H21NO2 , and molecular mass of 259.343 g/mol is marketed as Rozerem by Takeda Pharmaceuticals North America. It is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN), versus binding to GABA A receptors, such as with drugs like Ambien (zolpidem), eszopiclone, and zaleplon. Ramelteon is approved by the FDA for long-term use....." Read more about Rozerem |
|
To
Rotate Molecule
-->> To
Zoom-->> Jmol
Menu --->> To view Using Chime -- PDB Structure of Ramelteon Molecule NOTE: YOU MUST HAVE CHIME INSTALLED |
|